Neo-adjuvant chemotherapy used in esophageal carcinoma

Neoadjuvant chemotherapyNeoadjuvant chemotherapy is the administration of therapeutic agents before the main treatment.Neoadjuvant therapy aims to:Reduce the size or extent of cancer.Makes procedures easier and more likely to succeed.Reduces the consequences of a more extensive treatment.Single-agent chemotherapyCombination chemotherapyBleomycin5-fluorouracil (5-FU)CisplatinMitomycinCarboplatinVindesine and vinorelbinePaclitaxelDocetaxelEtoposideCisplatin and 5-FU - Most widely used.Epirubicin/Cisplatin/5-FUPaclitaxel/Cisplatin/5-FUDocetaxel/Cisplatin/5-FUIrinotecan Plus 5-FUOxaliplatin/Capecitabine